The Icahn School of Medicine at Mt. Sinai is a clinical research site located in New York, New York, United States 10029.
Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.
The Icahn School of Medicine at Mt. Sinai has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Non-Muscle Invasive Bladder Cancer (NMIBC), Coronary Artery Disease, Coronary Artery Calcification.
Sponsors: Asieris Pharmaceutical Technologies Co., Ltd., Bolt Medical.
Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The Icahn School of Medicine at Mt. Sinai has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Icahn School of Medicine at Mt. Sinai has 2 clinical trials on record, with 1 currently active. Their work covers Non-Muscle Invasive Bladder Cancer (NMIBC), Coronary Artery Disease, Coronary Artery Calcification.
The Icahn School of Medicine at Mt. Sinai has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.